Finally, the Zimmermann group has shown that intrathymic (i.t.)injection of AAV vectors into mice can achieve up to 5% thymocyte transduction efficiency32, and this can be used to correct immunodeficiency in ZAP70-deficient mice. Here, ZAP70 is linked to immunodeficiency disease.